Filter
Patient and Caregiver Preferences for Acute Seizure Medications: A Quantitative Survey
Patient and Caregiver Perceptions of Acute Seizure Medications and the Rapid and Early Seizure Termination (REST) Approach: Qualitative Interviews
Bridging the Divide: Enhancing Communication Between People Living With an Epilepsy and Their Healthcare Providers to Improve Care
Describing the Population of Patients With Prolonged Seizures: US Subgroup Results From a Global Real-World Point-in-Time Study
AAV Mediated Overexpression of STXBP1 Variants in a Mouse Model of STXBP1 Haploinsufficiency
Reactive Mouse Primary Astrocytes as a Model to Explore Glial Gene Expression Profiles Identified in Human Temporal Lobe Epilepsy
AAV Gene Therapy in Juvenile Mice of STXBP1 Haploinsufficiency
Healthcare Resource Utilization and Costs With the Introduction of Intranasal Midazolam in Acute Seizure Management: A Wisconsin-Based Claims Analysis
Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Seizures: Results of a Phase II/III, Open-Label, Randomized, Active Comparator Trial
Long-Term Use of Oral Lacosamide in Young Children With Epilepsy Who Received Lacosamide in Previous Trials: Data From a Multicenter, Open-Label, Follow-Up Trial
Association of Fenfluramine Treatment and Everyday Executive Functioning in Adults With Lennox-Gastaut Syndrome
Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Final Results From a Long-Term Open-Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients With Dravet or Lennox-Gastaut Syndromes
Mortality Rates and Risk Factors Among Patients With Lennox-Gastaut Syndrome or Dravet Syndrome
Impacts of Disruptive Seizures, Sleep, and Behaviors on Activities of Daily Living and Communication in Developmental and Epileptic Encephalopathies: Interim Results of a Caregiver Survey
Streamlining the Process of Caregiving for a Loved One with Dravet or Lennox-Gastaut Syndrome
Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Patients With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Digital Application Usage in Epilepsy: Insight From Real-World Setting Studies BRIVA-Reg and BRITOBA
Tolerability and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients With Focal Seizures: Phase 3, Open-Label Extension Trial
Fenfluramine Persistence in Patients With Lennox-Gastaut Syndrome: A Retrospective Analysis Using US Claims Data
Healthcare Resource Utilization and Antiseizure Medication Claims in Patients With Lennox-Gastaut Syndrome Receiving Fenfluramine in the United States